Opportunity Information: Apply for RFA DK 16 003
Apply for RFA DK 16 003
- The HHS-NIH11 in the food and nutrition, health sector is offering a public funding opportunity titled "Improving Diabetes Management in Children with Type 1 Diabetes (DP3)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847,.
- This funding opportunity was created on Dec 08, 2015 and posted on Dec 08, 2015.
- Applicants must submit their applications by Jun 22, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,400,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Improving Diabetes Management in Children with Type 1 Diabetes (DP3)" (Funding Opportunity Number RFA DK 16 003) is a discretionary NIH research grant issued by HHS (Agency: HHS-NIH11). Its central purpose is to fund projects that create and strengthen new, practical ways to help children with type 1 diabetes manage their condition more effectively during early childhood and the early elementary school years. The focus is specifically on two age groups that often face unique management challenges: very young children under 5 years old and school-aged children ages 5 to 9. The program is designed for research teams that are prepared to move beyond general ideas and into hands-on development work, where strategies are not only proposed but actually built, refined, and tried out in real-world or near-real-world settings.
The FOA emphasizes intervention development rather than large-scale definitive testing. Supported projects are expected to develop, refine, and pilot test innovative diabetes management strategies. Innovation here can reasonably include new behavioral approaches, family- or caregiver-focused supports, clinic-to-home coordination strategies, school-based supports, technology-enabled workflows, communication tools, training models, or other approaches that address the day-to-day realities of glucose monitoring, insulin administration, nutrition, activity, and safety for children in these age ranges. The key is that the work should lead to an intervention that is clearly defined and operationalized, not just a concept, and that the pilot work produces credible evidence about whether the approach can be delivered as intended and whether families and children will actually use it.
By the end of the funding period, the deliverable is expected to be a well-developed and well-characterized intervention. That means the strategy should be described in enough detail that others could understand what it is, who it is for, what components it includes, how it is delivered, and what resources are required. The intervention must also be shown to be safe, feasible to implement, and acceptable to the target population. Safety in this context relates to protecting children from avoidable risk while managing diabetes (for example, issues related to hypoglycemia, caregiver burden, or misapplication of tools), while feasibility and acceptability speak to whether the approach can realistically fit into the daily lives of families, childcare settings, and schools, and whether the people involved find it usable and worthwhile. If the pilot results are promising, the intervention should be positioned to move directly into a larger efficacy trial, meaning the groundwork should already be in place to test whether it produces measurable improvements when evaluated at a broader scale.
In terms of funding details, the opportunity lists an award ceiling of $1,400,000 and anticipates making about 3 awards. The activity categories connected to the announcement include health and food/nutrition, and it is associated with CFDA numbers 93.847 (and also 93.847 as listed). The original and current closing date for applications was June 22, 2016, and the announcement was posted and created on December 8, 2015. While those dates indicate the specific competition is historical, the summary still reflects the kind of project NIH was seeking under this FOA: intervention-oriented research that produces a tested, ready-to-scale program or tool for improving type 1 diabetes management among children in early childhood through age 9.
Eligibility is broad and includes many types of organizations that can carry out health research and intervention development. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding universities when specified); for-profit organizations other than small businesses; and small businesses. The inclusion of school districts and multiple government and community organization types aligns with the practical reality that diabetes management for children ages 5 to 9 often involves school settings, caregivers, and community infrastructure, not only clinical care.
Overall, the FOA is aimed at accelerating the pipeline from idea to actionable, field-tested intervention for pediatric type 1 diabetes management in younger children. Success under this program would look like a carefully designed approach that has been iteratively improved through early testing, demonstrates strong feasibility and acceptability with families and children, and is mature enough to justify investment in a larger, rigorous efficacy study.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Improving Diabetes Management in Children with Type 1 Diabetes (DP3)".
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA DK 16 003.
Which agency is offering this grant?
This is a discretionary NIH research grant issued by the U.S. Department of Health and Human Services (HHS), through NIH (Agency: HHS-NIH11).
What is the main goal of the program?
The central purpose is to fund projects that create and strengthen new, practical ways to help children with type 1 diabetes manage their condition more effectively during early childhood and the early elementary school years.
Which children are the focus of this FOA?
The FOA targets two age groups that commonly face unique diabetes management challenges:
- Very young children under 5 years old
- School-aged children ages 5 to 9
What types of projects is NIH looking for under this FOA?
The FOA is designed for research teams ready to move beyond general ideas into hands-on intervention development work, where strategies are built, refined, and pilot tested in real-world or near-real-world settings.
Is this grant meant for large-scale clinical trials?
No. The FOA emphasizes intervention development rather than large-scale definitive testing. Projects are expected to develop, refine, and pilot test innovative strategies rather than run a full, large efficacy trial during this funding period.
What does "intervention development" mean in this context?
It means the project should produce a diabetes management strategy that is clearly defined and operationalized (not just a concept), and that is refined through early testing to show it can be delivered as intended and is usable by families and children.
What kinds of interventions could be supported?
The FOA describes innovation broadly and indicates that supported work could reasonably include approaches such as:
- New behavioral approaches
- Family- or caregiver-focused supports
- Clinic-to-home coordination strategies
- School-based supports
- Technology-enabled workflows
- Communication tools
- Training models
- Other practical approaches addressing everyday realities like glucose monitoring, insulin administration, nutrition, activity, and safety
What outcomes or evidence should the pilot work produce?
The pilot work should produce credible evidence about whether the approach:
- Can be delivered as intended (implementation fidelity)
- Is feasible in real-life settings for families, childcare, and schools
- Is acceptable to children and families (and other involved caregivers/settings)
- Is actually used as expected (uptake and usability)
What is the expected deliverable by the end of the funding period?
By the end of the funding period, the expected deliverable is a well-developed and well-characterized intervention that is described clearly enough that others can understand what it is, who it is for, what it includes, how it is delivered, and what resources it requires.
What does "well-developed and well-characterized" mean?
It means the intervention should be documented in practical detail, including:
- Target population (who it is for)
- Core components (what it includes)
- Delivery approach (how it is delivered and in what settings)
- Operational requirements (what staffing, tools, training, and resources are needed)
What does the FOA mean by safety, feasibility, and acceptability?
According to the FOA summary:
- Safety: protecting children from avoidable risk while managing diabetes (for example, hypoglycemia risk, caregiver burden, or misapplication of tools)
- Feasibility: whether the approach can realistically fit into daily life for families and within childcare/school routines
- Acceptability: whether the people involved find the approach usable, appropriate, and worthwhile
Does the intervention need to be ready for a larger study afterward?
Yes. If pilot results are promising, the intervention should be positioned to move directly into a larger efficacy trial, meaning the project should build the groundwork needed for broader-scale evaluation.
How much funding is available per award?
The opportunity lists an award ceiling of $1,400,000.
How many awards were expected?
The FOA anticipated making about 3 awards.
What activity categories are associated with this announcement?
The activity categories connected to the announcement include health and food/nutrition.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.847 (listed as 93.847 in the provided information).
When was the announcement posted?
The announcement was posted/created on December 8, 2015.
What was the application closing date?
The original and current closing date for applications was June 22, 2016.
Is this a current funding opportunity?
Based on the provided dates, this specific competition appears to be historical. The summary still describes the type of intervention-oriented project NIH was seeking under this FOA.
Who is eligible to apply?
Eligibility is broad and includes many organization types capable of conducting health research and intervention development. Eligible applicants include:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Native American tribal governments (federally recognized)
- Native American tribal organizations (other than federally recognized tribal governments)
- Public housing authorities
- Indian housing authorities
- Nonprofits with 501(c)(3) status (excluding universities when specified)
- Nonprofits without 501(c)(3) status (excluding universities when specified)
- For-profit organizations other than small businesses
- Small businesses
Why are school districts specifically included as eligible applicants?
The inclusion of independent school districts aligns with the reality that diabetes management for children ages 5 to 9 often involves school settings, along with caregivers and community infrastructure, not only clinical care.
What would a strong project look like under this FOA?
Based on the summary, success would look like an approach that is carefully designed and iteratively improved through early testing, demonstrates strong feasibility and acceptability with families and children, and is mature enough to justify investment in a larger, rigorous efficacy study.
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Food and Nutrition, Health
Next opportunity: Notice of Intent to Issue Funding Opportunity Announcement “Hydrogen and Fuel Cell Technologies Research, Development, and Demonstrations” (No. DE-FOA-0001412)
Previous opportunity: NOTICE OF INTENT TO AWARD: Recreation Assistant Intern
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 16 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 16 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Human Pancreas Procurement and Analysis Program (HPPAP) (UC4) Apply for RFA DK 15 027 Funding Number: RFA DK 15 027 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $2,300,000 |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) Apply for PAS 16 033 Funding Number: PAS 16 033 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Improving Diabetes Management in Pre-teens, Adolescents and/or Young Adults with Type 1 Diabetes (DP3) Apply for RFA DK 16 001 Funding Number: RFA DK 16 001 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $1,400,000 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20) Apply for RFA DK 16 012 Funding Number: RFA DK 16 012 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Advancing Erythroid Cell Biology (R01) Apply for PA 16 039 Funding Number: PA 16 039 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development (SB1) Apply for PAR 16 027 Funding Number: PAR 16 027 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3) Apply for RFA DK 16 002 Funding Number: RFA DK 16 002 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $2,500,000 |
| Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) Apply for RFA DK 16 014 Funding Number: RFA DK 16 014 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Innovative Research in HIV in Kidney, Urology, and Hematology (R01) Apply for RFA DK 16 015 Funding Number: RFA DK 16 015 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $500,000 |
| George M. O'Brien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 16 013 Funding Number: RFA DK 16 013 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $1,000,000 |
| Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44) Apply for RFA DK 16 004 Funding Number: RFA DK 16 004 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Psychosocial and Behavioral Mechanisms in Bariatric Surgery (R01) Apply for RFA DK 16 017 Funding Number: RFA DK 16 017 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21) Apply for PAR 16 064 Funding Number: PAR 16 064 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $125,000 |
| Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24) Apply for RFA DK 16 507 Funding Number: RFA DK 16 507 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $1,000,000 |
| Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01) Apply for RFA DK 16 010 Funding Number: RFA DK 16 010 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $250,000 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 16 019 Funding Number: RFA DK 16 019 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $750,000 |
| NIDDK Program Projects (P01) Apply for PAR 16 127 Funding Number: PAR 16 127 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $6,250,000 |
| High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) Apply for PAR 16 126 Funding Number: PAR 16 126 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01) Apply for PAR 16 121 Funding Number: PAR 16 121 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Apply for PAR 16 148 Funding Number: PAR 16 148 Agency: HHS-NIH11 Category: Food and Nutrition, Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 16 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.